anonymous
Guest
anonymous
Guest
Keep dreaming "snowflake"!
Only a difference of opinion. Why so harsh?
Keep dreaming "snowflake"!
Most patients discontinue Restasis due to intolerance and/or lack of symptomatic relief.
Most patients discontinue Restasis due to intolerance and/or lack of symptomatic relief.
I heard from a credible source that they don’t want it to get any better. Which makes sense...when’s the last time you heard from management or marketing re: ideas of how to improve the volume of Rxs counted? **crickets**
I’m sure we all know a certain Detroit manager thats working on this. She can’t possibly not be number 1. There has to be a mistake . Meanwhile the rest of us are out here busting our asses
Ok i don’t know who wrote this but if you are worried about or selling to formulary access you really have no idea what you are doing.. i spend very little time talking about that.
Obviously, formulary discussions are not the way to sell the product. However, coverage does impact pull through and long term success. Think about it: over the course of a couple weeks Dr. Jones prescribes 20 Rxs of Cequa and after a stack of PAs and step edits only 2 patients end up filling their prescriptions... do you think Dr. Jones begins using more or less Cequa?
Salesforces help generate awareness and drive demand... but we are only one component of a successful product within the marketplace. If this weren’t true, why would Novartis have field access managers on their payroll, why does Sun have market access folks at home office on their payroll, and why is there such a large correlation between preferential Medicaid/Medicare/commercial coverage and territory launch performance?
You see me once in June, twice in November and not at all in May. What am I?Instead of asking silly rhetorical questions just answer them. Who needs these riddles?